Literature DB >> 3180374

Long-term outcome of patients undergoing surgical repair of isolated pulmonary valve stenosis. Follow-up at 20-30 years.

S L Kopecky1, B J Gersh, M D McGoon, D D Mair, C J Porter, D M Ilstrup, D C McGoon, J W Kirklin, G K Danielson.   

Abstract

In a group of 191 consecutive patients who underwent operation at the Mayo Clinic for isolated pulmonary valve stenosis between 1956 and 1967, late results were excellent. In patients surviving operation before the age of 21 years, long-term survival was similar to that in an age- and sex-matched control population. In the other patients, late survival and functional status were good, but survival was poorer than in the control population. This late attrition, most likely due to the sequelae of long-standing right ventricular hypertrophy, suggests the need for continued surveillance. Late sudden death occurred in only three patients, between 10 and 21 years postoperatively. The finding of normal life expectancy for such patients who survive operation before age 21 is important for actuarial purposes and for the patients' career and employment plans.

Entities:  

Mesh:

Year:  1988        PMID: 3180374     DOI: 10.1161/01.cir.78.5.1150

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  4 in total

Review 1.  Life insurance implications of mortality for up to 40 years after repair of congenital heart defects in childhood.

Authors:  G R Cumming
Journal:  J R Soc Med       Date:  1999-02       Impact factor: 5.344

2.  Survival with congenital heart disease and need for follow up in adult life.

Authors:  C Wren; J J O'Sullivan
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

3.  Brock transventricular pulmonary valvotomy in patients with pulmonary stenosis: long-term results.

Authors:  M Vogel; R Eger; W Klinner; K Bühlmeyer
Journal:  Pediatr Cardiol       Date:  1990-10       Impact factor: 1.655

4.  Quality of life in adults with congenital heart disease.

Authors:  D A Lane; G Y H Lip; T A Millane
Journal:  Heart       Date:  2002-07       Impact factor: 5.994

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.